Insider Trading Alert - SBRA, EXA And MNTA Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, May 8, 2015, 68 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $1,023.75 to $5,610,306.91.

Highlighted Stocks Traded by Insiders:

Sabra Health Care REIT (SBRA) - FREE Research Report

Ettl Robert A., who is Director at Sabra Health Care REIT, bought 3,500 shares at $27.95 on May 8, 2015. Following this transaction, the Director owned 37,455 shares meaning that the stake was boosted by 10.31% with the 3,500-share transaction.

The shares most recently traded at $27.77, down $0.18, or 0.65% since the insider transaction. Historical insider transactions for Sabra Health Care REIT go as follows:

  • 4-Week # shares sold: 2,500
  • 12-Week # shares bought: 800
  • 12-Week # shares sold: 2,500
  • 24-Week # shares bought: 800
  • 24-Week # shares sold: 2,500

The average volume for Sabra Health Care REIT has been 408,400 shares per day over the past 30 days. Sabra Health Care REIT has a market cap of $1.7 billion and is part of the financial sector and real estate industry. Shares are down 8.07% year-to-date as of the close of trading on Friday.

Sabra Health Care REIT, Inc. operates as a real estate investment trust in the United States. The company, through its subsidiaries, owns and invests in real estate properties for the healthcare industry. The stock currently has a dividend yield of 5.59%. The company has a P/E ratio of 21.3. Currently, there are 5 analysts who rate Sabra Health Care REIT a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SBRA - FREE

TheStreet Quant Ratings rates Sabra Health Care REIT as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Sabra Health Care REIT Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

3 Hold-Rated Dividend Stocks: TRGP, SBRA, APO

These 7 Stocks Are Spiking on Big Volume -- Here's How to Trade Them Now

What To Hold: 3 Hold-Rated Dividend Stocks SBRA, PIR, FTR

Strong On High Volume: Sabra Health Care REIT (SBRA)

3 Hold-Rated Dividend Stocks: CVA, SBRA, GME